Active Versus Sham Transcranial Pulsed Electromagnetic Field Headband Treatment for Major Depression: a Study Protocol for a Double-blinded Randomized Trial

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

An 8-week, two-armed, randomized-controlled trial that examines the antidepressant effect of treatment with transcranial pulsed electromagnetic fields (T-PEMF) in patients diagnosed with moderate to severe depression using using a new device, the MoodHeadBand (MHB). The participants will use an active or placebo MHB for 30 minutes daily for 8 weeks. Additionally, the following research questions will be answered: 1\. If there is a positive effect on the patients' emotional and non-emotional cognition after 8 weeks of active treatment compared to the sham group and if possible early changes in the emotional cognition can predict the treatment response after 8 weeks of treatment. 1\. If the T-PEMF treatment provides improvement in restorative sleep after 8 weeks of treatment

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 65
Healthy Volunteers: f
View:

• Meeting the diagnostic criteria for moderate to severe depressive episode without psychotic symptoms according to the International Classification of Diseases and Related Health Problems 10th Revision (ICD-10)(The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research 1993).

• Female participants: Females in the fertile age must deliver a negative pregnancy test, or previously have been sterilized.

• Female fertile participants: They must use safe contraceptive methods to be included in the study, and during the whole study.

• Has given written, informed consent to the trial.

Locations
Other Locations
Denmark
Psychiatric Center Copenhagen
RECRUITING
Frederiksberg
Contact Information
Primary
Martin B. Jørgensen, MD DMSc
Martin.Balslev.Joergensen@regionh.dk
23328669
Backup
Nana B Sørensen, MD
nana.brandborg.soerensen@regionh.dk
26356751
Time Frame
Start Date: 2024-06-17
Estimated Completion Date: 2026-08-30
Participants
Target number of participants: 117
Treatments
Experimental: (A) Patients diagnosed with moderate to severe depression without psychotic symptoms
In total, 48 patients will be allocated to this arm.~(In total, 117 patients will be included in the study. Data for the initial 21 patients included in the study could not be used to assess the antidepressant effect, why an increased number of participants was needed to secure the power for the trial. The technical difficulties have been addressed)
Sham_comparator: (B) Patients diagnosed with moderate to severe depression without psychotic symptoms
In total, 48 patients will be allocated to this arm.~(In total, 117 patients will be included in the study. Data for the initial 21 patients included in the study could not be used to assess the antidepressant effect, why an increased number of participants was needed to secure the power for the trial. The technical difficulties have been addressed)
Related Therapeutic Areas
Sponsors
Leads: Mental Health Services in the Capital Region, Denmark
Collaborators: Danish Medical Association, Doctor Gerhard Linds scholarship, MoodHeadBand Aps, Innovation Fund Denmark

This content was sourced from clinicaltrials.gov